Delivery Order SPE2DB22D2206-SPE2DB25FHC92
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $80,235.95. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed-price pricing type, and an ultimate completion date of March 4, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen in a 2 ml size. The contract, awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 28, 2025. The award has a ceiling value of $17,149.48 and is a firm fixed-price delivery order contract with a completion date of January 29, 2025. The contract does not have a set-aside designation. AmerisourceBergen holds a significant...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $18,856.42 firm fixed-price delivery order contract has a completion date of March 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for a ceiling value of $10,286.33. The contract is a delivery order with a firm fixed price pricing type, and the ultimate completion date is February 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen with a ceiling value of $35,108.30. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, with a ceiling value of $9,195.61. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $36,972.91. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 23, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $3,441.69 and a completion date of December 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen 2 ml, a prescription medication, to the Defense Logistics Agency (DLA). The $31,884.54 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 11, 2024, with a completion date of June 12, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, with a ceiling value of $15,972.40. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of July 15, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...